Adverse effects of Oxford-AstraZeneca COVID-19 vaccine among Egyptian healthcare workers

Kaffas, Mai Al; Aboelnour, Amal; H.Abuelela, Manal

doi:10.21608/mid.2022.148304.1337

Cited by 1 publication

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4,10 The most common events after the first dose of Pfizer were injection-site pain (71-83%), fatigue (34-47%), headache (25-42%), and AstraZeneca most frequently reported adverse effects in mild to moderate symptoms were bony aches (69.3%), fever (51.6%), localized arm pain (11.3%), and GIT disorder in the form of diarrhea (3.2%). [11][12][13] Individuals with evidence of past SARS-CoV-2 infection were also more likely to have adverse effects than those without evidence of past infection with both vaccines. Although it remains to be tested, it is possible that this increased reactogenicity relates to increased immunogenicity.…”

Section: Discussionmentioning

confidence: 99%

Characteristics of Adverse Events of Coronavirus Disease 2019 Vaccines First, Second and Booster

Probowati,

Jayadi,

Rustam

2023

BIKDW

View full text Add to dashboard Cite

Background Coronavirus Disease 2019 (COVID-19) was a new type of highly contagious disease that had a high risk of developing Acute Respiratory Distress Syndrome (ARDS). According to the World Health Organization (WHO), COVID-19 can be transmitted mainly through aerosol particles contiguous to another human in one meter. To cope with this pandemic, the government programmed vaccinations around the world, including in Indonesia. Objective This study provided new information about the description of the characteristics of adverse events following vaccination participation in vaccination COVID-19 first, second and booster doses. Method This descriptive research was conducted using a cross-sectional method. Subjects were populations with various characteristics at Bethesda Hospital, Bethesda Lempuyangwangi Hospital, and the Jawa Dayu Christian Church who had received the COVID-19 vaccine. The data were univariately presented as a distribution table using the IBM SPSS - Statistical Program for Social Science Statistics 23. Result From 400 respondents, the most common types of vaccine received during the first dose were Sinovac, the second dose of Sinovac, and the Moderna for booster dose. Conclusion The first dose was the same as the second dose. Most felt drowsiness 87.9%, swelling and pain at the injection site 77.9%, and weakness at 60.4%. In phase 1 clinical research of the mRNA vaccine from Moderna, side effects occurred in more than 50% of vaccination participants in the form of fatigue, chills, headache, myalgia, and pain at the injection site, especially at higher doses.

show abstract